ONYX PHARMACEUTICALS INC
ONXX
ONXX was delisted on the 30th of September, 2013.
0 hedge funds and large institutions have $0 invested in ONYX PHARMACEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 257 closing their positions.
100% less funds holding
Funds holding: 258 → 0 (-258)
100% less funds holding in top 10
Funds holding in top 10: 46 → 0 (-46)
100% less capital invested
Capital invested by funds: $7.38B → $0 (-$7.38B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 257
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$512M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$421M |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
-$393M |
| 4 |
HI
HBK Investments
Dallas,
Texas
|
-$339M |
| 5 |
D.E. Shaw & Co
New York
|
-$259M |
ONXX Hedge Fund Activity: Q4 2013 in Review
0 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ONYX PHARMACEUTICALS INC (ONXX) for Q4 2013, worth a combined $0 — down 100% from $7.38B a quarter earlier.
Sellers outnumbered buyers: 257 funds closed out of ONXX and 0 opened new positions — a net loss of 257 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Adage Capital Partners, exiting entirely with an estimated $512M sold.
- 0 institutional investors held ONYX PHARMACEUTICALS INC (ONXX) as of Q4 2013, down from 258 in Q3 2013.
- Funds reported $0 of ONYX PHARMACEUTICALS INC stock for Q4 2013, down 100% quarter-over-quarter.
- 0 funds opened new ONYX PHARMACEUTICALS INC positions in Q4 2013 and 257 closed out, a net change of -257 holders.
- The largest ONYX PHARMACEUTICALS INC seller in Q4 2013 was Adage Capital Partners, an estimated $512M sold.
Based on aggregated 13F filings for Q4 2013.